Source: BioPharma-Reporter

Koneksa: Koneksa launches academic collaboration for Parkinson's research

Digital biomarker company Koneksa has launched the first collaboration in the Koneska Academic Partnership Program for Parkinsonâs Disease (KAPP-PD) to incorporate its Neuroscience Toolkit into research programs.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Chris Benko's photo - Co-Founder & CEO of Koneksa

Co-Founder & CEO

Chris Benko

CEO Approval Rating

90/100

Read more